Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial

Neuropsychopharmacology

Volumn 20, Issue 4, 1999, Pages 380-385

  Smeraldi, Enrico ^a   Benedetti, Francesco ^a   Barbini, Barbara ^a   Campori, Euridice ^a   Colombo, Cristina ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Bipolar disorder; Lithium; Pindolol; Sleep deprivation

Indexed keywords

PINDOLOL;

ADULT; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SLEEP DEPRIVATION;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; ADULT; AFFECT; BIPOLAR DISORDER; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PINDOLOL; PSYCHIATRIC STATUS RATING SCALES; SLEEP DEPRIVATION;

EID: 0033059018     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00129-8     Document Type: Article

References (52)

1. Aitken R.C.B. Measurement of feelings using visual analogue scale. Proc R Soc Med. 62:1969;989-993.
2. American Psychiatric Association (1994): Diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV). Washington, American Psychiatric Association Press.
3. American Psychiatric Association (1995): Practice guideline for treatment of patients with bipolar disorder. Washington, American Psychiatric Association Press.
4. Artigas F., Perez V., Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry. 51:1994;248-251.
5. Artigas F. Pindolol, 5-hydroxytryptamine, and antidepressant augmentation. Arch Gen Psychiatry. 52:1995;969-970.
6. 1A antagonists. TINS. 19:1996;378-383.
7. Asikainen M., Deboer T., Porkka-Heiskanen T., Stenberg D., Tobler I. Sleep deprivation increases brain serotonin turnover in the Djungarian hamster. Neurosci Lett. 198:1995;21-24.
8. Baxter L.R., Liston E.H., Schwartz J.M., Altshuler L.L., Wilkins J.N., Richeimer S., Guze B.H. Prolongation of the antidepressant response to partial sleep deprivation by lithium. Psychiatry Res. 19:1986;17-23.
9. Benedetti F., Barbini B., Campori E., Colombo C., Smeraldi E. Dopamine agonist amineptine prevents the antidepressant effect of sleep deprivation. Psychiatry Res. 65:1996;179-184.
10. Benedetti F., Barbini B., Lucca A., Campori E., Colombo C., Smeraldi E. Sleep deprivation hastens the antidepressant action of fluoxetine. Eur Arch Psychiat Clin Neurosci. 247:1997;100-103.
11. Berman R.M., Darnell A.M., Miller H.L., Anand A., Charney D.S. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression. A double-blind, placebo-controlled trial Am J Psychiatry. 154:1997;37-43.
12. Betts T.A., Alford C. β-blockers and sleep. a controlled trail Eur J Clin Pharmacol. 28(Suppl):1985;65-68.
13. Blier P., Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol. 15:1995;217-222.
14. Blier P., de Montigny C., Chaput Y. A role for the serotonin system in the mechanism of action of antidepressant treatments. preclinical evidence J Clin Psychiatry. 51(4 Suppl):1990;14-20.
15. Charney D.S., Heninger G.R., Sternberg D.E. Serotonin function and the mechanism of action of antidepressant treatment. Arch Gen Psychiatry. 41:1984;359-365.
16. Cramer H., Tagliamonte A., Tagliamonte P., Perez-Cruet J., Gessa G.L. Stimulation of brain serotonin turnover by paradoxical sleep deprivation in intact and hypophysectomized rats. Brain Res. 54:1973;373-375.
17. Elsenga S, Van den Hoofdakker RH (1982-1983): Clinical effects of sleep deprivation and clomipramine in endogenous depression. J Psychiatry Res 17:361-374.
18. Fornal C.A., Jacobs B.L. Physiological and behavioral correlates of serotonergic single-unit activity. Osborne N.N., Hamon M. Neuronal serotonin. 1988;305-345 Wiley & Sons, New York.
19. Fornal C.A., Metzler C.W., Gallegos R.A., Veasey S.C., McCreary A.C., Jacobs B.L. WAY-100635, a potent and selective 5-hydroxytriptamine(1A) antagonist, increases serotonergic neuronal activity in behaving cats. Comparison with (S)WAY-100135 J Pharmacol Exp Ther. 278:1996;752-762.
20. Gardner J.P., Fornal C.A., Jacobs B.L. Effects of sleep deprivation on serotonergic neuronal activity in the dorsal raphe nucleus of the freely moving cat. Neuropsychopharmacology. 17:1997;72-81.
21. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
22. Hery F., Pujol J.F., Lopez M., Macon J., Glowinski J. Increased synthesis and utilization of serotonin in the central nervous system of the rat during paradoxical sleep deprivation. Brain Res. 21:1970;391-403.
23. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo. A microdialysis study J Neurochem. 60:1993;776-779.
24. Holsboer-Trachsler E., Hemmeter U., Hatzinger M., Seifritz E., Gerhard U., Hobi V. Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment. neurobiological and psychometric assessment of course J Psychiatr Res. 28:1994;381-399.
25. Kostis J.B., Rosen R.C. Central nervous system effects of β-adrenergic-blocking drugs. The role of ancillary preperties Circulation. 75:1987;204-212.
26. Kuhs H., Farber D., Borgstadt S., Mrosek S., Tolle R. Amitriptyline in combination with repeated late sleep deprivation versus amitriptyline alone in major depression. A randomised study. J Affect Dis. 37:1996;31-41.
27. Leibenluft E., Wehr T.A. Is sleep deprivation useful in the treatment of depression? Am J Psychiatry. 149:1992;159-168.
28. Leonard C.S., Llinàs R. Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep. An in vitro electrophysiological study Neuroscience. 59:1994;309-330.
29. Maudhuit C., Jolas T., Chastanet M., Hamon M., Adrien J. Reduced inhibitory potency of serotonin reuptake blockers on central serotoninergic neurons in rats selectively deprived of rapid eye movement sleep. Biol Psychiatry. 40:1996;1000-1007.
30. Monti J.M., Jantos H. Stereoselective antagonism by the pindolol enantionmers of 8-OH-DPAT-induced changes of sleep and wakefulness. Neuropharmacology. 33:1994;705-708.
31. Moreno F.A., Gelenberg A.J., Bachar K., Delgado P. Pindolol augmentation of treatment resistant depressed patients. J Clin Psychiatry. 58:1997;437-439.
32. National Institute of Mental Health Research (NIMH), Department of Education and Welfare (1976): ECDEU Assessment Manual. Levin J, Guy W, eds. Rockville, MD, National Institute of Mental Health.
33. Neckelmann D., Bjorkum A.A., Bjorvatn B., Ursin R. Sleep and EEG power spectrum effects of the 5-HT1A antagonist NAN-190. Behav Brain Res. 75:1996;159-168.
34. Perez V., Gilaberte I., Faries D., Alvarez E., Artigas F. Randomised, double-blind placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet. 349:1997;1594-1597.
35. Petrie W.M., Maffucci R.J., Woosley R.L. Propanolol and depression. Am J Psychiatry. 139:1982;92-94.
36. Price L.H., Heninger G.R. Lithium in the treatment of mood disorders. N Engl J Med. 331:1994;591-598.
37. 1A receptors. In vivo microdialysis and electrophysiological studies in the rat brain Neuropsychopharmacol. 15:1996;349-360.
38. Salomon R.M., Delgado P.L., Licinio J., Krystal J.H., Heninger G.R., Charney D.S. Effects of sleep deprivation on serotonin function in depression. Biol Psychiatry. 36:1994;840-846.
39. Santos R., Carlini E.A. Serotonin receptors activation in rats previously deprived of REM sleep. Pharmacol Biochem Behav. 18:1983;501-507.
40. Shelton R.C., Loosen P.T. Sleep deprivation accelerates the response to nortryptiline. Prog Neuropsychopharmacol Biol Psychiatry. 17:1993;113-123.
41. Solomon R.L., Rich C.L., Darko D.F. Antidepressant treatment and the occurrence of mania in bipolar patients admitted for depression. J Affect Disord. 18:1990;253-257.
42. Szuba M.P., Baxter L.R., Altshuler L.L., Allen E.M., Guze B.H., Schwartz J.M., Liston E.H. Lithium sustains the antidepressant effects of sleep deprivation. Preliminary findings from a controlled study Psychiatry Res. 51:1994;283-295.
43. Statistica 4.5. Windows version. Tulsa, OK, StatSoft Inc., 1993.
44. Tome M.B., Isaac M.T., Harte R., Holland C. Paroxetine and pindolol. A randomized trial of serotonergic autoreceptor blocked in the reduction of antidepressant latency Int Clin Psychopharmacol. 12:1997;81-89. a.
45. Tome M.B., Cloninger C.R., Watson J.P., Isaac M.T. Serotonergic autoreceptor blockade in the reduction of antidepressant latency. Personality variables and response to paroxetine and pindolol J Affect Disord. 44:1997;101-109. b.
46. Vogel G.W., Vogel F., McAbee R.S., Thurmond A.J. Improvement of depression by REM sleep deprivation. Arch Gen Psychiatry. 37:1980;247-253.
47. Waal H.J. Propanolol-induced depression. Br Med J. 2:1967;50.
48. Wehr T.A., Goodwin F.K., Wirz-Justice A., Brietmeier J., Craig C. 48-hour sleep-wake cycles in manic depressive illness. Naturalistic observations and sleep deprivation experiments. Arch Gen Psychiatry. 39:1982;559-565.
49. Wehr T.A. Improvement of depression and triggering of mania by sleep deprivation. JAMA. 267:1992;548-551.
50. Wu J.C., Bunney W.E. The biological basis of an antidepressant response to sleep deprivation and relapse. Review and hypothesis Am J Psychiatry. 147:1990;14-21.
51. Zanardi R., Artigas F., Franchini L., Sforzini L., Gasperini M., Smeraldi E., Perez J. How long should pindolol be associated with paroxetine to improve the antidepressant response? J Clin Psychopharmacol. 17:1997;446-450.
52. Zanardi R., Franchini L., Gasperini M., Lucca A., Smeraldi E., Perez J. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression. A controlled study J Clin Psychopharmacol. in press:1998.